QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360) (QAIAx)

QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (UPSTO App No(s). 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428) is Frontier AI/AGI Public Health Trials Sandbox Framework That Provides Free Public Health Services to Registered and Sponsored Visitors/Occupants for RDT&E Under 28 U.S.C. 1498 (Classified as a PPA, OTA Under 10 U.S. Code 4001, 4022), Serving as a Global Intranet of Humans Resident Patients Among Multiple Enclave Communicates ("AI Microcities" or "Smart Health Cities") Living and Learning With AI Robotics for Non-medicinal Treatment.

BRIEF SUMMARY

A. "What is the purpose of this study?"

This study will test whether the "AI City Hall Project" (QAIAx), a quantum artificial intelligence (AI) public health agency, can provide free or low-cost behavioral and mental health services inside self-contained, dome-enclosed communities called "Microcities". Researchers want to see if AI-managed public administration, AI humanoid robots, holoportation of human-figures via 'holo-suites' (e.g., AI-119 Kikkeri Holo-Suit; AI-119 Vulcan QM-Ware) and advanced AI mental-health tools can lower housing and care costs, improve mental health outcomes (e.g., particular ecosystems using AI tools among persons with one or more addiction disorders), and be financially sustainable for people on fixed incomes or public assistance.

B. "What conditions does the study focus on?"

The study focuses on adults with:

• Autism spectrum disorders (Asperger's, autism, ADHD, ASD)
• Substance use disorders (alcohol, opioids, marijuana, cocaine, MDMA/ecstasy, tobacco/nicotine)
• Psychiatric conditions (personality disorders, narcissism, gender dysphoria, eating disorders)
• Behavioral addictions (gambling, sex addiction) and related issues (sex offence history).

C. "What does the study involve?"

Eligible volunteers live in an omni AI-managed Microcity for up to 24 months. The community is housed in a geodesic dome that contains all daily necessities: housing, food, utilities, healthcare, and public services. Daily life is managed by an AI system (ISAC) and AI humanoid robots, with only occasional human oversight. Participants receive free mental-health treatment that may include AI-driven counselling, virtual-reality therapy (holo-suits), and non-invasive digital "attitude inoculation" protocols designed to reduce stress and addiction cravings. All participants also take AI-technology courses as a condition of enrolment. The study does not use any FDA-regulated drug, device, or biologic.

**Who can participate?**

You may be able to join if you:

• Are an adult (18 years or older)
• Have a diagnosis of one of the listed mental-health or addiction disorders
• Are referred by a licensed health professional (e.g., RN, NP, PhD, MD), a non-profit organization (e.g., 501(c)(3), university, church), or a public agency (e.g., case manager, social worker, parole/probation officer, judge)
• Are willing to live in a closed, AI-managed community for up to one year and complete AI educational courses.

Participants who are veterans, receive public assistance (e.g., VA disability, SSDI/SSI, Medicaid, Medicare), or are experiencing homelessness may be prioritized.

**Where is the study taking place?** The study will be conducted at Microcity sites in the United States and internationally. The first administrative site is in Richmond, Virginia, USA. Additional sites are planned in partner nations, including tribal lands, military installations, and special economic zones.

**Who is sponsoring the study?** The study is sponsored by Veterans Recovery Network Inc., a SCDV-owned non-profit organization, in collaboration with AI-119 Vulcan Project Research & Educational Technology Co. (PRETCO). The study is conducted under U.S. federal research and development authorities (28 U.S.C. §1498; 10 U.S.C. §§§§ 4001, 4021, 4022, and 4023) and is part of a Cooperative Research and Development Agreement (CRADA) with participating segments or RDT&E programming missions of the United States Defense Department (DoW).

This summary describes a planned clinical study. Not all details may be final. Information may change as the study progresses.

Study Overview

• Status: Not yet recruiting
• Conditions: ADHD; Narcotic-Related Disorders; Opiate Substitution Treatment; Autism; Psychiatric Disorder; ASD; Gambling Disorder; Homelessness; Anger Problems; Asperger's Disorder; Psychedelic Experiences; Alcohol Addiction; Narcotic Addiction; Sex Behavior; Cocaine Abuse; Smoking Abstinence; Child Abuse, Sexual; Asperger Disorder; Alcohol Abuse/Dependence; Sex Disorders; Autism Disorder; Reliability and Validity; Marijuana Use Disorder; ADHD - Attention Deficit Disorder With Hyperactivity; Homeless and Low Incomes People, Refugees; Smoking (Tobacco) Addiction; Opioid Abuse and Addiction; MDMA ('Ecstasy'); Sex Disorder; Alcohol and Other Substance Use Prevention; Alcohol and Other Drug Use Disorders; Psychedelic Drug Dependence; Opioid Abuse (Disorder); Smoking Among Youth; Marijuana Abuse and Dependence; Gambling Addiction; Gender Dysphoria, Adult; Sex Crimes; Abstinence, Sex; Sex Abuse; Narcissism; Addiction Disorders; Eating Behavior Disorders; Psychedelic Effects in Healthy Volunteers
• Intervention / Treatment: Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

Detailed Description

1. PROGRAM OVERVIEW & MISSION

A. Statutory Authority and Mission

The QAIAx Clinical Trial (NIH PSR ID: NCT07661823) is a large-scale, multi-year Research, Development, Test, and Evaluation (RDT&E) program conducted under the authority of 10 U.S.C. §§§§ 4001, 4021, 4022, and 4023, utilizing Other Transaction Authority (OTA). This framework establishes specialized RDT&E enclaves, designated as "Microcities," on closed U.S. military installations, designated research sites (e.g., FFRDC, UARC, Enhanced Use Lease (EUL under Permanent Air-Gapped Enclosures - 10 U.S.C. 2667, 10 U.S.C. 2808a), tribal lands (ISDEAA collaborative; e.g., private-fee land or temporary DoD easement), or global special economic zones in nexus with active bilateral treatise as ).

B. Program Mission The mission is to evaluate whether a quantum artificial intelligence public health agency, utilizing non-medicinal AI robotics, can deliver free or low-cost behavioral and mental health services within self-contained, dome-enclosed communities. This "AI City Hall Project" leverages AI-managed public administration, AI humanoid robots, and holoportation remote command to serve individuals on fixed incomes or public assistance.

C. Trial Scale and Pre-Launch Status Total Enrollment: The multi-year study targets a total enrollment of 1,000,000 participants across a global network of 300 Microcities.

Capacity: Each facility will house between 1,500 and 15,000 occupants. The initial live-in phase requires 50,000 patients and 5,000 trainees.

Timeline: Operations are scheduled to run from early 2027 through the end of 2028. The project remains in a pre-launch phase until 1 July 2027.

Coordination: A pre-launch coordination sync will occur via Zoom on September 27, 2026 to announce initial enclave sponsors, microcity locations, enrollment execution data, and other critical updates about the clinical trial.

• Study Type: Interventional
• Enrollment (Estimated): 1000000
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: RDTE Administrator; Phone Number: 888-307-8380; Email: admin@qaiax.org
• Study Contact Backup: Name: C Peterson, Administrator; Phone Number: 804-390-5037; Email: rdte@vetsrecovery.org

Study Locations

• United States
  • Virginia
    • Richmond, Virginia, United States, 23219
      • Administrative Office

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Individuals aged 17 to 99 years old.
• Referral by a licensed health services professional (e.g., R.N., N.P., Ph.D., M.D.).
• Referral by a non-profit organization (e.g., 501c3, university, church).
• Referral by a public agency (e.g., case manager, social worker, parole/probation/PTS officer, judge).

Exclusion Criteria:

* Individuals under 17 or over 99 years of age.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Non-Randomized
• Interventional Model: Sequential Assignment
• Masking: None (Open Label)

Number of Arms

11

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: AI Public Health Central (Group 1)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 2)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 3)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 4)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 5)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 6)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 7)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 8)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 9)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 10)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Experimental: AI Public Health Central (Group 11)	Behavioral: AI City Hall Project (AIhealth4u - Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation); Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central); QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Vulcan QAIAx v4.0x (Beta ISAC) for AI-119 and AI Wat (1498) patent series for Private, Public, and Military sectors (Change from Baseline in Participant Lifestyle Efficiency, Behavioral Stability, & Sovereign Resource Allocation via Vulcan QAIAx v4.0)	This comprehensive description bridges the clinical parameters of the AI-119 Vulcan SOF Program (an AGI/AI Ecosystems RDT&E Program launched under the 119th U.S. Congress) and Veterans Recovery Network Program (VA-authorized program, est. 2020, Richmond VAMC) with the high-velocity public, private, and military administrative functions optimized by the AI-119 and AI Wat patent series under 28 U.S.C. § 1498 (Government Use of Patents), using a Omni-AI robotics among Holo-Suit, Quasi-Mind Ware (QM-Ware), Body-Ware, QAIA Humanoid (via "AI-Me" Hybrid AI Symbiote app). This primary outcome measures the definitive capacity of the Vulcan QAIAx v4.0x (Beta ISAC) autonomous platform to generate an efficient lifestyle, stabilize severe psychiatric and addiction disorders, and optimize administrative resource delivery across Private, Public, and Military sector frameworks. Utilizing a '90/10' hybrid workforce model (90% omni-AI Humanoid Workforce / 10% Human Auditor & Administrator oversight).	Baseline enrollment, month 12, and month 24 (tracked monthly)
Change from Baseline in Participant Lifestyle Efficiency and Behavioral Stability Index (via QAIAx 4.0x Core Analytics)	The primary outcome directly track the core clinical and lifestyle stabilization of the veterans residing in the monitored Microcity ecosystem, measuring the effectiveness of the advanced AI/AGI tools. Total duration (measured in months vs. the traditional multi-year trajectories) and accuracy rate of AI-driven legal/health document processing, error corrections, and intake evaluations managed by the 90% AI Humanoid Workforce under human auditor ethical oversight under 'Kikkeri doctrine' to 'hire a million to skill a billion.'	Baseline enrollment, month 12, and month 24 (tracked monthly)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Economic Sustainability and Housing Retention Cost Index under the Omni-AI Microcity Model	Total financial variance and cost-mitigation rates achieved by housing occupants within the $100 to $2,000 per month extreme-affordability bracket (including digital device provisioning and logistics integration), evaluated against standard public healthcare and federal housing expenditure benchmarks.	Baseline enrollment, month 12, and month 24 (tracked monthly)

Collaborators and Investigators

• Sponsor: Veterans Recovery Network Inc.
• Collaborators: Central Virginia VA Health Care System; U.S. Special Operations Command; AI-119 Vulcan Project Research & Educational Technology Company (fka Henry Nanpei Academy Project)

Publications and helpful links

Helpful Links

• AI-119 Vulcan Proposes Hybrid AI Governance System to Address Camp Lejeune Claims Backlog
• 'AI City Hall Project' Unveiled as Viable Hybrid AI Fix for CLJA Claims Crisis (Veterans First for America)
• Acknowledgment Notice (Veterans Recovery Network Program - Veterans Affairs Richmond VA.Gov Authorization_Letter to Veterans Recovery_Network Inc.)
• Mental Health Primary Care (MHPC) SUD Program Guidelines for Non-Treatment Seeking Veterans (9/22/2023)
• Cognitive Behavioral Therapy for Substance Use Disorders Among Veterans - Therapist Manual (2023, Rev. Ed.): VA framework formally links the protocol to the underlying clinical care continuum established by PMID: 24052453
• QAIAx TDC Model Code Statement - USPTO Patent App. 64105164 (ex rel. 'QAIAx' Clinical Trial (PRS NCT07661823)
• PROGRAM PRESS RELEASE (6-26-2026) QAIAx Clinical Trial Update
• New 'Digital DNA' project aims to keep human identity alive in humanoid robot after death A 40-sensor haptic suit could map a person's movements, vital signs, skills and identity into a "Digital DNA" profile
• QAIAx Proposes $1 Million 'Digital DNA' Plan to Replicate People for 500 Years
• 新"数字DNA"项目旨在让人死后以人形机器人延续其身份 知新了了 知新了了 2026-07-28 11:27 一套配备40个传感器的触觉服，能将人的动作、生命体征、技能和身份映射为一份"数字DNA"档案。
• Video Content QAIAx Microcities Clinical Trial (General Program Details)
• Program Press Release (8-2-2026) - Program Update and Opportunities Brief for the QAIAx Clinical Trial (NIHPSR ID: NCT07661823)

Study record dates

Study Major Dates

• Study Start (Estimated): September 1, 2026
• Primary Completion (Estimated): September 30, 2045
• Study Completion (Estimated): December 31, 2045

Study Registration Dates

• First Submitted: June 6, 2026
• First Submitted That Met QC Criteria: June 16, 2026
• First Posted (Actual): June 22, 2026

Study Record Updates

• Last Update Posted (Actual): September 4, 2026
• Last Update Submitted That Met QC Criteria: September 1, 2026
• Last Verified: September 1, 2026

More Information

Terms related to this study

• Keywords: artificial intelligence; veterans; military; mental health treatment; ai city hall project; ai 119; ai119; qaia; qaiax; ai wat; veterans recovery network; addiction disorder; vulcan; agi; sex addiction; smart health cities; microcities; smartcities; smart city; omni ai
• Additional Relevant MeSH Terms: Autism Spectrum Disorder; Urogenital Diseases; Genital Diseases; Substance-Related Disorders; Chemically-Induced Disorders; Alcohol-Related Disorders; Neurodevelopmental Disorders; Child Development Disorders, Pervasive; Sexual Dysfunctions, Psychological; Attention Deficit and Disruptive Behavior Disorders; Compulsive Behavior; Impulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Sexual and Gender Disorders; Behavior; Risk-Taking; Gender Dysphoria; Narcotic-Related Disorders; Compulsive Sexual Behavior Disorder; Opioid-Related Disorders; Alcoholism; Mental Disorders; Autistic Disorder; Marijuana Abuse; Attention Deficit Disorder with Hyperactivity; Asperger Syndrome; Behavior, Addictive; Cocaine-Related Disorders; Gambling; Sexual Dysfunction, Physiological; Smoking; Sexual Behavior; Coitus; Sexual Abstinence
• Other Study ID Numbers: QAIAx; Vulcan SOF S/C (RDT&E) #26915 (Other Grant/Funding Number: AI-119 Vulcan PRETCO (JATF Vulcan SOF Program RDT&E)); PMID: 24052453 (Other Identifier: VA Alcohol Care Management (ACM) RCT Continuum); VA-RICH-VRNI-2023 (Other Identifier: Richmond VAMC (VA Department))

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No